% Expired Patents = 50.0

EPO Patents = 3

Forward Citations = 1

Loading Chart...

10 inventors (with patents filed for the assignee):

Kouji Matsushima (3 out of 39 patents)

Satoru Ito (2 out of 28 patents)

Satoshi Ueha (2 out of 6 patents)

4. Shin-ichi Hashimoto (2 out of 2 patents)

5. Shuichi Kaneko (2 out of 18 patents)

6. Yoshiro Ishiwata (2 out of 20 patents)

7. Shoji Yokochi (2 out of 12 patents)

8. Takayoshi Shirasaki (1 out of 1 patent)

9. Masao Honda (1 out of 5 patents)

10. Taro Yamashita (1 out of 6 patents)

4 patents: Sort by Forward Citations

1. 11168137 - Method for reducing side effects of immune checkpoint control agent (2021-11-09),

2. 10746726 - Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient (2020-08-18),

3. 10738352 - Method for analyzing nucleic acid derived from single cell (2020-08-11),

4. 10709727 - Antiviral drugs (2020-07-14),

Idac Theranostics, Inc. is a biotechnology company focused on developing innovative molecular diagnostics and therapeutics for personalized medicine. Our cutting-edge technology enables early and accurate diagnosis of various diseases, leading to targeted treatment strategies. We are committed to improving patient outcomes and revolutionizing healthcare through precision medicine.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#3,053 in Tokyo

#7,573 in Japan

Tokyo, Japan

Idac Theranostics, Inc.